Soluble fibrinogen-like protein 2/fibroleukin exhibits immunosuppressive properties: Suppressing T cell proliferation and inhibiting maturation of bone marrow-derived dendritic cells

Journal of Immunology

Volumn 170, Issue 8, 2003, Pages 4036-4044

  Chan, Camie W Y ^a   Kay, Lyndsey S ^a   Khadaroo, Rachel G ^a   Chan, Matthew W C ^a   Lakatoo, Sophia ^a   Young, Kevin J ^a   Zhang, Li ^a   Gorczynski, Reginald M ^a   Cattral, Mark ^a   Rotstein, Ori ^a   Levy, Gary A ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CONCANAVALIN A; FIBRINOGEN LIKE PROTEIN 2; FIBRINOGEN VARIANT; FIBROLEUKIN; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD28; MONOCLONAL ANTIBODY CD3; UNCLASSIFIED DRUG;

ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BACULOVIRUS EXPRESSION SYSTEM; BONE MARROW CELL; CELL ACTIVITY; CELL CULTURE; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DOSE RESPONSE; FEMALE; IMMUNE DEFICIENCY; MOUSE; NONHUMAN; POLARIZATION; PRIORITY JOURNAL; T LYMPHOCYTE; TH2 CELL;

EID: 0037446535     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.8.4036     Document Type: Article

References (40)

1. Doolittle, R. F. 1983. The structure and evolution of vertebrate fibrinogen. Ann. NY Acad. Sci. 408:13.
2. Procopio, W. N., P. I. Pelavin, W. M. Lee, and N. M. Yeilding. 1999. Angiopoietin-1 and -2 coiled coil domains mediate distinct homo-oligomerization patterns, but fibrinogen-like domains mediate ligand activity. J. Biol. Chem. 274:30196.
3. Chiquet-Ehrismann, R., C. Hagios, and K. Matsumoto. 1994. The tenascin gene family. Perspect. Dev. Neurobiol. 2:3.
4. Tsakadze, N. L., Z. Zhao, and S. E. D'Souza. 2002. Interactions of intercellular adhesion molecule-1 with fibrinogen. Trends Cardiovasc. Med. 12:101.
5. Sitrin, R. G., P. M. Pan, S. Srikanth, and R. F. Todd, III. 1998. Fibrinogen activates NF-κB transcription factors in mononuclear phagocytes. J. Immunol. 161:1462.
6. Papapetropoulos, A., G. Garcia-Cardena, T. J. Dengler, P. C. Maisonpierre, G. D. Yancopoulos, and W. C. Sessa. 1999. Direct actions of angiopoietin-1 on human endothelium: evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors. Lab. Invest. 79:213.
7. Hemesath, T. J., L. S. Marton, and K. Stefansson. 1994. Inhibition of T cell activation by the extracellular matrix protein tenascin. J. Immunol. 152:5199.
8. Ruegg, C. R., R. Chiquet-Ehrismann, and S. S. Alkan. 1989. Tenascin, an extracellular matrix protein, exerts immunomodulatory activities. Proc. Natl. Acad. Sci. USA 86:7437.
9. Ding, J. W., Q. Ning, M. F. Liu, A. Lai, J. Leibowitz, K. M. Peltekian, E. H. Cole, L. S. Fung, C. Holloway, P. A. Marsden, et al. 1997. Fulminant hepatic failure in murine hepatitis virus strain 3 infection: tissue-specific expression of a novel fgl2 prothrombinase. J. Virol. 71:9223.
10. Clark, D. A., G. Chaouat, P. C. Arck, H. W. Mittruecker, and G. A. Levy. 1998. Cytokine-dependent abortion in CBA X DBA/2 mice is mediated by the procoagulant fgl2 prothrombinase (correction of prothombinase). J. Immunol. 160:545.
11. Clark, D. A., J. W. Ding, G. Yu, G. A. Levy, and R. M. Gorczynski. 2001. fgl2 prothrombinase expression in mouse trophoblast and decidua triggers abortion but may be countered by OX-2. Mol. Hum. Reprod. 7:185.
12. Koyama, T., L. R. Hall, W. G. Haser, S. Tonegawa, and H. Saito. 1987. Structure of a cytotoxic T-lymphocyte-specific gene shows a strong homology to fibrinogen β and γ chains. Proc. Natl. Acad. Sci. USA 84:1609.
13. Levy, G., and M. Abecassis. 1989. Activation of the immune coagulation system by murine hepatitis virus strain 3. Rev. Infect. Dis. 11(Suppl. 4):S712.
14. Parr, R. L., L. Fung, J. Reneker, N. Myers-Mason, J. L. Leibowitz, and G. Levy. 1995. Association of mouse fibrinogen-like protein with murine hepatitis virus-induced prothrombinase activity. J. Virol. 69:5033.
15. Fung, L. S., G. Neil, J. Leibowitz, E. H. Cole, S. Chung, A. Crow, and G. A. Levy. 1991. Monoclonal antibody analysis of a unique macrophage procoagulant activity induced by murine hepatitis virus strain 3 infection. J. Biol. Chem. 266:1789.
16. Ding, J. W., Q. Ning, M. F. Liu, A. Lai, K. Peltekian, L. Fung, C. Holloway, H. Yeger, M. J. Phillips, and G. A. Levy. 1998. Expression of the fgl2 and its protein product (prothrombinase) in tissues during murine hepatitis virus strain-3 (MHV-3) infection. Adv. Exp. Med. Biol. 440:609.
17. Marazzi, S., S. Blum, R. Hartmann, D. Gundersen, M. Schreyer, S. Argraves, V. von Fliedner, R. Pytela, and C. Ruegg. 1998. Characterization of human fibroleukin, a fibrinogen-like protein secreted by T lymphocytes. J. Immunol. 161:138.
18. Ruegg, C., and R. Pytela. 1995. Sequence of a human transcript expressed in T-lymphocytes and encoding a fibrinogen-like protein. Gene 160:257.
19. Kohno, T., R. Moriuchi, S. Katamine, Y. Yamada, M. Tomonaga, and T. Matsuyama. 2000. Identification of genes associated with the progression of adult T cell leukemia (ATL). Jpn. J. Cancer Res. 91:1103.
20. Chan, C. W., M. W. Chan, M. Liu, L. Fung, E. H. Cole, J. L. Leibowitz, P. A. Marsden, D. A. Clark, and G. A. Levy. 2002. Kinetic analysis of a unique direct prothrombinase, fgl2, and identification of a serine residue critical for the prothrombinase activity. J. Immunol. 168:5170.
21. Gorczynski, R. M. 2001. Role of cytokines in allograft rejection. Current Pharmaceutical Design 7:1039.
22. Brand, K., S. Page, G. Rogler, A. Bartsch, R. Brandl, R. Knuechel, M. Page, C. Kaltschmidt, P. A. Baeuerle, and D. Neumeier. 1996. Activated transcription factor nuclear factor-κB is present in the atherosclerotic lesion. J. Clin. Invest. 97:1715.
23. Li, X. C., A. D. Wells, T. B. Strom, and L. A. Turka. 2000. The role of T cell apoptosis in transplantation tolerance. Curr. Opin. Immunol. 12:522.
24. Morelli, A. E., H. Hackstein, and A. W. Thomson. 2001. Potential of tolerogenic dendritic cells for transplantation. Semin. Immunol. 13:323.
25. -) induce alloantigen-specific hyporesponsiveness in murine T lymphocytes. Transplantation 60:1539.
26. Fu, F., Y. Li, S. Qian, L. Lu, F. D. Chambers, T. E. Starzl, J. J. Fung, and A. W. Thomson. 1997. Costimulatory molecule-deficient dendritic cell progenitors induce T cell hyporesponsiveness in vitro and prolong the survival of vascularized cardiac allografts. Transplant. Proc. 29:1310.
27. Lu, L., and A. W. Thomson. 2002. Manipulation of dendritic cells for tolerance induction in transplantation and autoimmune disease. Transplantation 73:S19.
28. Levy, G. A., M. Liu, J. Ding, S. Yuwaraj, J. Leibowitz, P. A. Marsden, Q. Ning, A. Kovalinka, and M. J. Phillips. 2000. Molecular and functional analysis of the human prothrombinase gene (HFGL2) and its role in viral hepatitis. Am. J. Pathol. 156:1217.
29. Auffermann-Gretzinger, S., E. B. Keeffe, and S. Levy. 2001. Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection. Blood 97:3171.
30. Kakumu, S., S. Ito, T. Ishikawa, Y. Mita, T. Tagaya, Y. Fukuzawa, and K. Yoshioka. 2000. Decreased function of peripheral blood dendritic cells in patients with hepatocellular carcinoma with hepatitis B and C virus infection. J. Gastroenterol. Hepatol. 15:431.
31. + monocytes as dendritic cell precursors: diverse maturation-inducing pathways lead to common activation of NF-κ/RelB. Crit. Rev. Immunol. 21:179.
32. Neumann, M., H. Fries, C. Scheicher, P. Keikavoussi, A. Kolb-Maurer, E. Brocker, E. Serfling, and E. Kampgen. 2000. Differential expression of Rel/ NF-κB and octamer factors is a hallmark of the generation and maturation of dendritic cells. Blood 95:277.
33. Romagnani, S. 2000. T-cell subsets (Th1 versus Th2). Ann. Allergy Asthma Immunol. 85:9.
34. Lucey, D. R., M. Clerici, and G. M. Shearer. 1996. Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. Clin. Microbiol. Rev. 9:532.
35. Ganschow, R., D. C. Broering, D. Nolkemper, J. Albani, M. J. Kemper, X. Rogiers, and M. Burdelski. 2001. Th2 cytokine profile in infants predisposes to improved graft acceptance after liver transplantation. Transplantation 72:929.
36. Ranger, A. M., M. P. Das, V. K. Kuchroo, and L. H. Glimcher. 1996. B7-2 (CD86) is essential for the development of IL-4-producing T cells. Int. Immunol. 8:1549.
37. Rulifson, I. C., A. I. Sperling, P. E. Fields, F. W. Fitch, and J. A. Bluestone. 1997. CD28 costimulation promotes the production of Th2 cytokines. J. Immunol. 158:658.
38. Fowell, D. J., J. Magram, C. W. Turck, N. Killeen, and R. M. Locksley. 1997. Impaired Th2 subset development in the absence of CD4. Immunity 6:559.
39. + T cells. Immunity 11:399.
40. +1 T cells into high IL-4-producing effectors. Int. Arch Allergy. Immunol. 118:384.